Not Yet Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT06899464
Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial (CLINCH)
Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage
Sponsor: Cardinal Stefan Wyszynski University
Interventions
14-day Cerebrolysin treatment Standard of Care (SOC)
Updated 1 time since 2025 Last updated: Mar 21, 2025 Started: Oct 1, 2025 Primary completion: Jan 1, 2027 Completion: Apr 1, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Hemorrhagic Stroke and Hemorrhagic Stroke, Intracerebral, this trial is actively recruiting participants. The trial is conducted by Cardinal Stefan Wyszynski University and has accumulated 1 data snapshot since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE4
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Cardinal Stefan Wyszynski University
Data source: Cardinal Stefan Wyszynski University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.